Index Subjects a-25 dihydroxyvitamin D; and Ia expression, 266 Pinkus’ Guide to Dermatohistopathology, 5th edition. a#-MSH and skin pigmentation (Case report), 286 A.H.Mehregan and K. Hashimoto, 530 Acanthosis nigricans, nicotinic acid and type V hyperlipidae- Principle and Practice of Dermatology. W.M.Sams and mia (Case report), 412 P.J.Lynch (Editors), 208 AIDS, acral hyperpigmented macules and longitudinal mela- Psoriasis. H.H.Roenigk and H.I.Maibach (Editors), 209 noychia (Case report), 387 Sexually Transmitted Diseases—A Textbook of Genitourinary AIDS-related Kaposi’s sarcoma (Case report), 74 Medicine. G.W.Csonka and J.K.Oates (Editors), 208 Alopecia areata, serum and hair growth, 166 Tumours of the Epidermis. K.Hashimoto and A.H.Mehregan, Antibiotic resistance and coagulase-negative staphylococci, 532 586 Bradykinin and skin, 111 Antifungal agents and interactions. Suppl. 39, 19 British Association of University Teachers of Dermatology Aphthous ulcers and 5-amino-salicylic acid, 185 (BAUTOD) (Correspondence), 201 Atopic eczema and Chinese medicinal plants, 179 Bullous pemphigoid antigen and interferon-gamma, 468 Atopic eczema and eosinophil cationic protein, 351 Bullous pemphigoid and hemiplegia (Case report), 614 Atopic eczema and sweating response, 346 Bullous pemphigoid and IgE antibodies (Correspondence), 526 Atopic skin, sweating and vasoconstrictive response, 246 Bullous pemphigoid and split skin immunofluorescence and Atopic skin and friction, capacitance and transepidermal water immunoblotting, 236 loss, 137 Bullous pemphigoid and sun exposure (Correspondence), 91 Azoles, allylamines and drug metabolism, Suppl. 39, 14 Calmodulin and systemic sclerosis, 231 Bacillary angiomatosis (Review), 535 Cancer family syndrome (Case report), 83 Blue naevus, giant scalp nodule (Case report), 375 Capsaicin and skin, 111 Book Reviews: Carney’s complex (Case report), 367 Atlas of Cutaneous Laser Surgery. D.B.Apfelberg (Editor), Carpal tunnel syndrome and autonomic neuropathy (Case 531 report), 611 Atlas of Infections of the Skin. A.DuVivier, 530 Chronic urticaria and warfarin (Correspondence), 415 Atlas of Skin Cancer. A.DuVivier, 530 Class II antigen expression and bullous pemphigoid, 463 Colour Atlas of Sexually Transmitted Diseases. L.C.Parish, Class II antigen expression and fibroblasts in scleroderma, 431 V.N.Sehgal and D.M.Buntin, 207 Collagen gene expression and fibroblasts in morphoea, 216 Current Problems in Dermatology Vol. 20. Metabolic Disorders Collagen type VII and dystrophic epidermolysis bullosa, 222 and Nutrition Correlated with Skin. B.J.Vermeer et al. Colophony and hand dermatitis, 161 (Editors), 532 Crohn’s disease and hidradenitis suppurativa (Correspon- Cutaneous Adnexal Tumours: A Guide to Pathologic Diagnosis. dence), 523 M.R.Wick and P.E.Swanson, 530 Crohn’s disease and oral intraepidermal IgA pustulosis (Case Dermatology in Europe. E.Panconesi (Editor), 531 report), 383 Exogenous Dermatoses: Environmental Dermatitis. T.Menne Cutaneous lymphoma, T-cell-receptor gene rearrangement and H.I.Maibach (Editors), 530 and ultrastructural studies (Case report), 404 Genetic Disorders of the Skin. J.C.Alper (Editor), 207 Cutanecus lymphoma and erythrodermic prodrome (Case Genital Papillomavirus Infections: Modern Diagnosis and Treat- report), 297 ment. G.Gross, S.Jablonska, H.Pfister and H.E.Stegner, Cutaneous oxygen tension and topical steroids, 502 208 Cutaneous T-cell lymphoma and My7 (CD13) antigen, 320 Guide de Dermato-Allergologie Professionnelle. ].Foussereau, Cyclosporin A and psoriasis (Report of a Meeting), 621 531 Cytokeratin and psoriasis treatment, 356 Malignant Skin Tumours. A.J.J.Emmett and M.G.E.O’Rourke (Editors), 209 Neoplasms with Eccrine Differentiation. P.Abenoza and Darier’s disease and vesiculo-bullous presentation (Correspon- A.Bernard, 305 dence), 416 Paediatrics in the Tropics. R.G.Hendrickse, D.G.D.Barr and Dermatitis artefacta (Case report), 86 T.S.Matthews (Editors), 207 Desmosomes in ichthyosis vulgaris, 24 Physicians Guide to Sunscreens. N.J.Lowe (Editor), 209 Dihydroxyacetone and UVA protection (Correspondence), 94 625 626 SUBJECT INDEX Discoid lupus erythematosus and chronic granulomatous Lymphocyte trafficking in inflammatory dermatoses (Review), disease, 60 711 Discoid lupus erythematosus and scarring alopecia, 307 Lymphomatoid papulosis and lymphoma, 596 Eccrine syringofibroadenoma and cytokeratins, 257 Malignant melanoma and HIV-infection, 516 Ehlers—Danlos syndrome type VIIB (Case report), 77 Malignant melanoma, Breslow thickness and public education Eosinophilic pustular folliculitis and HIV infection (Case (Correspondence), 206 report), 392 Malignant melanoma, desmoplastic (Correspondence), 301 Epidermolysis bullosa simplex (Dowling—Meara), 421 Malignant melanoma and re-excision of scar, 47 Eruptive histiocytoma (Case report), 196 Malignant melanoma and ungual origin (Correspondence), Erythema gyratum repens and Langerhans cells (Case report), 529 189 Melanocyte cultures and staurosporine, PMA and A23187, Erythema multiforme and hepatitis B vaccine (Correspon- 118 dence), 94 Melanoma cell lines, hyperthermia and killer cells, 131 Melanoma cells in culture and effect of HuIFN-f, 324 Fixed drug eruption and mefenamic acid (Case report), 409 Mercury allergy and lichenoid oral lesions, 10 Foetal antigen 2 and wound healing, 148 Methotrexate and non-steroidal anti-inflammatory drugs (Cor- Fusidic acid levels and blister fluid, 591 respondence), 95 Micrographic surgery and tissue preparation, 57 Glucocorticoids and procollagen, 172 Morphoea and collagen gene expression, 216 Glycosaminoglycans and dermal papilla cells, 479 Myiasis due to Cordylobia rodhaini (Correspondence), 418 Glycosaminoglycans and systemic sclerosis, 29 Granulomatous slack skin, 142 Necrobiosis lipoidica and systemic steroids, 542 Griseofulvin and serum lipids (Correspondence), 202 Nickel sensitivity, ear piercing and atopy, 16 Gulf War and dermatological problems (Correspondence), 200 Onychomatrixoma, 510 Hailey-Hailey disease, 275 Onychomycosis and prevalence in U.K. Suppl. 39, 23 Herpes simplex virus and erythema multiforme, 19 Hidradenitis suppurativa and etretinate (Correspondence), Papular mucinosis (Case report), 2&3 415 Paraphenylenediamine and oxidative stress, 450 HIV-infection and molluscum contagiosum (Correspondence), Pemphigoid gestationis antigen and basal keratinocytes, 42 528 Perforating collagenosis and Down’s syndrome (Case report), Hydroxychloroquine and atopic eczema (Correspondence), 93 71 Hyperhidrosis and clonazepam (Correspondence), 416 Pityriasis rubra pilaris and HIV-infection (Case report), 617 Plasmacytoma and intralesional tumour necrosis factor (Case Indomethacin and dithranol inflammation, 262 report), 395 Infectious erythemas in children (Correspondence), 302 Plasminogen binding in skin, 35 Interferon-gamma and HT-180 cells, 331 Pleomorphic T-cell lymphoma of the skin, 456 Interleukin-1 and contact sensitivity, 125 Porphyria cutanea tarda and erythrocyte uroporphyrinogen Iron and skin inflammation, 250 decarboxylase, 446 Itch and haemodialysis (Correspondence), 95 Post-irradiation scalp skin scales and ‘tin-tack’ sign (Corre- spondence), 90 Juvenile xanthogranuloma (Case report), 66 Prolidase deficiency and blood transfusion (Case report), 193 Propionibacterium acnes, effects of zinc and erythromycin, 505 Kaposi’s sarcoma and chylous ascites (Case report), 378 Prostaglandin E, and skin, 111 Keratin expression and basal cell carcinomas, 154 Pruritic dermatoses of pregnancy and IgM antibasement Keratinocytes, interleukin-1 augmentation by retinoid, 485 membrane antibodies, 474 Klippel-Trenaunay syndrome and genetics, 603 Psoriasis, psoriatic arthritis and Sj6gren’s syndrome, 242 Psoriasis area and severity index (Correspondence), 205 Lamellar bodies and hydrolytic enzymes, 337 Psoriasis and coal tar treatment, 608 Langerhans cell tumour (Case report), 398 Psoriasis and cyclosporin A (Report of a Meeting), 621 Leg ulcers and pericapillary fibrin, 582 Psoriasis and cytokines, 105 Lichenoid oral lesions and amalgam restorations, 10 Psoriasis and immunology (Review), 1 Lupus erythematosus and fatality (Correspondence), 303 Psoriasis and intravital video-capillaroscopy, 436 Lymphangioma (Case report), 380 Psoriasis, keratinocytes and Lt-fucose expression, 575 SUBJECT INDEX 627 Psoriasis and microvascular changes, 569 Terbinafine and antibacterial activity. Suppl. 39, 56 Psoriasis and scarring alopecia (Correspondence), 524 Terbinafine and fungal disease. Suppl. 39, 61 Psoriasis treatment and immunocyte response, 356 Terbinafine and its N-demethylated metabolite. Suppl. 39, 8 Pustular psoriasis and atypical presentation (Correspondence), Terbinafine and nail pharmacokinetics. Suppl. 39, 28 417 Terbinafine and onychomycosis. Suppl. 39, 40 Terbinafine short-duration therapy and onychomycosis. Retinoic acid receptors and molecular biology (Review), 97 Suppl. 39, 33 Ro antigen expression by keratinocytes and hormonal stimuli, Terbinafine and sporotrichosis. Suppl. 39, 51 554 Terbinafine and squalene epoxidase inhibition. Suppl. 39, 2 Ro antigen expression by keratinocytes and ultraviolet radia- Terbinafine treatment duration and onychomycosis. Suppl. tion, 546 39, 36 Thalidomide and erythema multiforme (Correspondence), 92 Scabies, herpes simplex and leukaemia (Correspondence), 523 Scabies and renal transplant recipient (Correspondence), 204 Ultraviolet B erythema response and chronological age, 315 Scarring alopecia and psoriasis (Correspondence), 524 Ultraviolet radiation and Ro antigen expression by keratino- Scleredema of Buschke and malignant insulinoma (Correspon- cytes, 546 dence), 527 Seborrhoeic dermatitis and Hailey—Hailey disease (Case Vasculitis and atherosclerosis (Correspondence), 90 report), 294 Vitamin D; analogue MC903 and psoriasis (Correspondence), Spitz naevus of the toe, 520 302 Staphylococcus aureus and isotretinoin therapy, 362 Vulvar dermatoses and allergic contact dermatitis, 52 Sweet’s syndrome and interleukin 1 (Correspondence), 201 Systemic sclerosis and endothelial studies, 561 Xanthogranulomatous inflammation (Case report), 290 Systemic sclerosis and y-interferon, 496 Xeroderma pigmentosum and bone marrow failure (Case Terbinafine and tinea capitis. Suppl. 39, 47 report), 372 Authors ABDULLAH, M.S. see BARTON, S.P. BARNETT, E.L. see WILLIAMS, R.E.A. ABEL, S.M. see BACK, D. J. BARTLETT, W. see PEARS, J.S. AELVOET, G.E., JORENS, P.G. and ROELEN, L.M. Genetic BARTON, S. see ELSAYED-ALI, H. aspects of the Klippel-Trenaunay syndrome, 603 BARTON, S.P., ABDULLAH, M.S. and MARKS, R. Quan- AITCHISON, T.C. see WILLIAMS, R.E.A. tification of microvascular changes in the skin in AKIMOTO, S., HAYASHI, H. and ISHIKAWA, H. Disac- patients with psoriasis, 569 charide analysis of the skin glycosaminoglycans in BATES, D.O. see BULL, R.H. systemic sclerosis, 29 BAUDRAZ-ROSSELET, F., RAKOSI, T., WILI, P.B., AKIYAMA, M. and KIKUCHI, A. KENZELMANN, R. Treatment of onychomycosis AL-IMARA, L. see BAKER, B.S. with terbinafine, Suppl. 39, 40 ALLEN, S.G. see HENG, M.C.Y. BEER, W.E. see MORGAN, G.W. ALTMANNSBERGER, M. see ECKERT, F. BEHR, J. see HEIN, R. ANDERSEN, J.A. see BOJE RASMUSSEN, H. BELJAARDS, R.C. and WILLEMZE, R. The prognosis of ANDERSON, J.A. see ROGERS, S. patients with lymphomatoid papulosis associated ARAKAWA, M. see HATAMOCHI, A. with malignant lymphomas, 596 ASHCROFT, A.T.T. see TAYLOR, M. BELLOSTA, M. see BERARDESCA, E. ASLANZADEH, J., HELM, K.F., ESPY, M.J., MULLER, S.A. BERARDESCA, E., FIDELI, D., BELLOSTA, M., DYNE, and SMITH, T.F. Detection of HSV-specific DNA in K.M., ZANABONI, G. and CETTA, G. Blood trans- biopsy tissue of patients with erythema multiforme fusions in the therapy of a case of prolidase by polymerase chain reaction, 19 deficiency, 193 ASSAY, B. see GILHAR, A. BERGER, T.G. see MARTIN, A.G. ATHERTON, D.J. see SALOB, S.P. BERNARD, P. see ZURN, A. ATHERTON, D.J. see SHEEHAN, M.P. BERTH-JONES, J., FLETCHER, A. and HUTCHINSON, AUTIO, P. see OIKARINEN, A. P.E. Epidermal cytokeratin and immunocyte AXELL, T. see LODEN, M. responses during treatment of psoriasis with calcipo- triol and betamethasone valerate, 356 BACK, D.J., TJIA, J.F. and ABEL, S.M. Azoles, allylamines BINGHAM, E.A. see HANDLEY, J. and drug metabolism, Suppl. 39, 14 BIRGITTE LANE, E. see MARKEY, A.C. BACK, O. and LINNA, J. In-vivo administration of BLACK, M.M. see KELLY, S.E. interleukin 1 both enhances and suppresses contact BLAKE, D.R. see TRENAM, C.W. sensitivity in the mouse, 125 BLETRY, O. see BRANCHET, M.C. BAKER, B.S., BRENT, L., VALDIMARSSON, H., BODOKH, I. see GALLAIS, V. POWLES, A.V., AL-IMARA, L., WALKER, M. and BOISNIC, S. see BRANCHET, M.C. FRY, L. Is epidermal cell proliferation in psoriatic skin BOJAR, R.A. see HOLLAND, K.T. grafts on nude mice driven by T-cell derived cyto- BOJE RASMUSSEN, H., TEISNER, B., ANDERSEN, J.A., kines?, 105 YDE-ANDERSEN, E. and LEIGH, I. Foetal antigen 2 BAKER, B.S. and FRY, L. The immunology of psoriasis (FA2) in relation to wound healing and fibroblast (Review), 1 proliferation, 148 BALSLEV, E., THOMSEN, H.K., DANIELSEN, L. and BORRADORI, L., SAADA, V., RYBOJAD, M., FLAGEUL, WARBURG, F. The occurrence of pericapillary fibrin B., KUFFER, R., LEMANN, M., VEROLA, O., in venous hypertension and ischaemic leg ulcers: a MODIGLIANI, R. and MOREL, P. Oral intraepidermal histopathological study, 582 IgA pustulosis and Crohn’s disease, 383 BAN, M. see TANI, M. BONSMANN, G. see KOLDE, G. BARAN, R. and KINT, A. Onychomatrixoma. Filamen- BRANCHET, M.C., BOISNIC, S., BLETRY, O., ROBERT, tous tufted tumour in the matrix of a funnel-shaped L., CHARRON, D. and FRANCES, C. Expression of nail: a new entity (report of three cases), 510 HLA class II antigens on skin fibroblasts in sclero- BARKER, J.N.W.N. and MACDONALD, D.M. Cutaneous derma, 431 lymphocyte trafficking in the inflammatory derma- BRAUN-FALCO, O. see HEIN, R. toses (Review), 211 BRAUTIGAM, M. see NOLTING, S. BARLOW, R.J. and GREAVES, M.W. Warfarin in the BRECKENRIDGE, A. Clinical significance of interactions treatment of chronic urticaria/angio-oedema (Corre- with antifungal agents, Suppl. 39, 19 spondence), 415 BRENT, L. see BAKER, B.S. 628 AUTHOR INDEX 629 BROWNING, M.C.K. see PEARS, J.S. MCCARTAN, B. Psoriasis, psoriatic arthritis and the BUCCHI, L., SERAFINI, M., CRISANTI, E., STANGA- possible association with Sjégren’s syndrome, 242 NELLI, I. and RAFANELLI, S. Malignant melanoma, COLVER, G.B. and GAWKRODGER, D.J. Vesiculo-bul- Breslow thickness and public education campaigns lous Darier’s disease (Correspondence), 416 (Correspondence), 205 COOK, M.G. see FALLOWFIELD, M.E. BUCKLEY, C. see HARRIS, D.W.S. COPEMAN, P.W.M. see COLLIER, P.M. BUCKLEY, C., THOMAS, V., CROW, J., HOULSTON, R.., CORK, M.J. see MCDONAGH, A.J.G. SLACK, J. and RUSTIN, M.H.A. Cancer family syn- COULSON, I.H., MALLETT, R.B. and HOLDEN, C.A. drome associated with multiple malignant melano- Acral persistent papular mucinosis, 283 mas and a malignant fibrous histicytoma, 83 COX, N.H., DIFFEY, B.L., FARR, P.M. The relationship BULL, R.H., BATES, D.O. and MORTIMER, P.S. Intravital between chronological age and the erythemal video-capillaroscopy for the study of the microcircu- response to ultraviolet B radiation, 315 lation in psoriasis, 436 COX, N.H. and WILKINSON, D.S. Dermatitis artefacta as BUREAU, B. see DRENO, B. the presenting feature of auto-erythrocyte sensitiza- BURGE, S. see MARREN, P. tion syndrome and naproxen-induced pseudopor- BURGE, S.M. see WILSON, C.L. phyria in a single patient, 86 BURGE, S.M. Hailey-Hailey disease: the clinical features, COX, N.H., LARGE, D.M., PATERSON, W.D. and IVE, response to treatment and prognosis, 275 F.A. Blisters, ulceration and autonomic neuropathy BURGE, S.M., MARSHALL, J.M. and CEDERHOLM-WIL- in carpal tunnel syndrome, 611 LIAMS, S.A. Plasminogen binding sites in normal CRAMB, R.B. see LIDDLE, B.J. human skin, 35 CRIJNS, M.B. see VAN DER SCHROEFF, J.G. BURROWS, N.P. and RUSSELL-JONES, R. Crohn’s dis- CRISANTI, E. see BUCCHI, L. ease in association with hidradenitis suppurativa, CROW, J. see BUCKLEY, C. 523 CUNLIFFE, W.J. see HOLLAND, K.T. BURY, H.P.R. see KO, C.B. CURLEY, G.K. see MALLET, R.B. CUTCLIFFE, A.G. see HOLLAND, K.T. CAMP, R.D.R. see ROSS, J.S. CZECH, W., KRUTMANN, J., SCHOPF, E. and KAPP, A. CARMICHAEL, A.J., MCHUGH, M.I. and MARTIN, A.M. Serum eosinophil cationic protein (ECP) is a sensitive Itch unrelated to adequacy of haemodialysis (Corre- measure for disease activity in atopic dermatitis, 351 spondence), 95 CARSON, D. see HANDLEY, J. CEDERHOLM-WILLIAMS, S.A. see BURGE, S.M. DABBAGH, A.J. see TRENAM, C.W. CELEBI, C.R. see ZURN, A. DANIELSEN, L. see BALSLEV, E. CERIO, R. see HELM, K.P. DARLEY, C. see MCGREGOR, J.M. CERIO, R. see ROSS, J.S. DAVID, M. see GILHAR, A. CETTA, G. see BERARDESCA, E. DAWBER, R.P.R. see WILSON, C.L. CHANG, A. see VAN DE KERKHOBF, P.C.M. DE BERKER, D.A.R., WILSON, C.L. and MILLARD, P.R. CHANG, W.L. and YOUNG, S.R. Sun-induced localized Reactive perforating collagenosis and Down’s syn- bullous pemphigoid (Correspondence), 91 drome, 71 CHARRON, D. see BRANCHET, M.C. DE GROOT, W.P. see POPE, F.M. CHOW, E.T.Y. and MORTIMER, P.S. Successful treat- DE LUCA, C. see PICARDO, M. ment of hidradenitis suppurativa and retroauricular DE WIT, R.F.E. see VAN DER SCHROEFF, J.G. acne with etretinate (Correspondence), 415 DEAN, D. see VENNING, V.A. CIRKEL, P.K.S. see VAN DER SCHROEEF, J.G. DEAN, D. see WILSON, C.L. CIVATTE, J. see MOISSON, Y.F. DENTON, K., WILSON, C.J. and VENNING, V.A. Primary COATES, P., SHUTTLEWORTH, D. and REES, A. Resolu- cutaneous anaplastic large-cell lymphoma with a tion of nicotinic acid-induced acanthosis nigricans prolonged erythrodermic prodrome, 297 by substitution of an analogue (acipimox) in a DIDIERJEAN, L. see ZURN, A. patient with type V hyperlipidaemia, 412 DIFFEY, B.L. see COX, N.H. COCKERELL, C.J. see MARTIN, A.G. DOBOZY, A. see KOSZO, F. COCKERELL, C.J. see WEBSTER, G.F. DOHERTY, V.R. see WILLIAMS, R.E.A. COLLIER, P.M., NEILL, S.M. and COPEMAN, P.W.M. DOLMANS, W.M.V. see KOOPMAN, R.]J.J. Topical 5-aminosalicylic acid: a treatment for DRENO, B., FLEISCHMANN, M., VALARD, S., aphthous ulcers, 185 GODEFROY, W., BUREAU, B., STADLER, J.F. and COLLINS, P., ROGERS, S., JACKSON, J. and LITOUX, P. Induction of myelo-monocytic My7 630 AUTHOR INDEX antigen (CD13) expression by interferon « in basal GALEA, G. see YEAMAN, G.R. cells of cutaneous T-cell lymphomas, 320 GALLAIS, V., LACOUR, J.PH., PERRIN, C., GHANEM, G., DYNE, K.M. see BERARDESCA, E. BODOKH, I. and ORTONNE, J.P. Acral hyperpig- mented macules and longitudinal melanonychia in EADY, E.A. see HOLLAND, K.T. AIDS patients, 387 EADY, R.A.J. see MCGRATH, J.A. GASPARRO, F.P. see TOKURA, Y. ECKERT, F., NILLES, M. and ALTMANNSBERGER, M. GAUCHERAND, M. see MACHADO, P. Eccrine syringofibroadenoma: a case report with GAWKRODGER. D.J. see COLVER, G.B. analysis of cytokeratin expression, 257 GAWKRODGER, D.J. see MCDONAGH, A,J.G. EDELSON, R.L. see TOKURA, Y. GHADIALLY, R. see MENON, G.K. ELIAS, P.M. see MENON, G.K. GHANEM, G. see GALLAIS, V. ELSAYED-ALI, H., BARTON, S. and MARKS, R. Stereo- GIBSON, W.T. see TAYLOR, M. logical studies of desmosomes in ichthyosis vulgaris, GILHAR, A., PILLAR, T., ASSAY, B. and DAVID, M. 24 Failure of passive transfer of serum from patients ESPY, M.J. see ASLANZADEH, J. with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp FAGGIONI, A. see PICARDO, M. skin grafted on to nude mice, 166 FALLOWFIELD, M.E. and COOK, M.G. Re-excisions of GILLESPIE, S.H. see OSTLERE, L.S. scar in primary cutaneous melanoma: a histopatho- GODEFROY, W. see DRENO, B. logical study, 47 GOODFIELD, M.J.D. Short-duration therapy with terbi- FAROOQ, L. see HOLLAND, K.T. nafine for dermatophyte onychomycosis: A multi- FARR, P.M. see COX, N.H. centre trial. Suppl. 39, 33 FARRELL, A.M. see HOLLAND, K.T. GOVAERT, F.J. see VAN DER SCHROEFF, J.G. FIDELI, D. see BERARDESCA, E. GRASS, P. see KOVARIK, J.M. FIELDING, P. see FREEMONT, A.J. GREAVES, M.W. see BARLOW, R.]. FIFE, K.M., TALBOT, D.C., MORTIMER, P., FISHER, C. GREENSTONE, M. see KO, C.B. and SMITH, I.E. Chylous ascites in Kaposi’s sarcoma: GRIBBON, E.M. see HOLLAND, K.T. a case report, 378 GRIFFITHS, R.W. see MCDONAGH, A.J.G. FINLAY, A.Y. Pharmacokinetics of terbinafine in the GROENEWEG, D.A. see VAN DER SCHROEFF, J.G. nail. Suppl. 39, 28 GUDMUNDSEN, K., OTRIDGE, B. and MURPHY, G.M. FINLAY, A.Y. see LONG, C.C. Fulminant fatal lupus erythematosus (Correspon- FIORAVANTI, M.L. see PAMPIGLIONE, S. dence), 303 FISHER, C. see FIFE, K.M. FLAGEUL, B. see BORRADORI, L. FLEISCHMANN, M. see DRENO, B. HADDEN, D. see HANDLEY, J. FLEMING, S. see KELLY, S.E. HAKANSON, R. see WALLENGREN, J. FLETCHER, A. see BERTH-JONES, J. HANDLEY, J., CARSON, D., SLOAN, J., WALSH, M.., FOGLIA, A.N. see HARKAWAY, K.S. THORNTON, C., HADDEN, D. and BINGHAM, E.A. FORSSELL, H. see LAINE, J. Multiple lentigines, myxoid tumours and endocrine FRANCES, C. see BRANCHET, M.C. overactivity: four cases of Carney’s complex, 367 FREEMONT, A.J., HOYLAND, J., FIELDING, P., HODSON, HAPPONEN, R-P. see LAINE, J. N. and JAYSON, M.I.V. Studies of the microvascular HARA, M. see MATSUNAGA, J. endothelium in uninvolved skin of patients with HARIA, M., O’NEILL, R.C. and WRIGHT, S. The effect of systemic sclerosis: direct evidence for a generalized topical steroids on cutaneous oxygen tension, 502 microangiopathy, 561 HARKAWAY, K.S., MCGINLEY, K.J., FOGLIA, A.N., LEE, FRIED, F. see HARKAWAY, K.S. W-L., FRIED, F., SHALITA, A.R. and LEYDEN, J.J. FRIEDMAN-KIEN, A.E. see WEBSTER, G.F. Antibiotic resistance patterns in coagulase-negative FROEBEL, K. see YEAMAN, G.R. staphylococci after treatment with topical erythro- FRY, L. see BAKER, B.S. mycin, benzoyl peroxide, and combination therapy, FUKUDA, M. see MAEDA, K. 586 FUKUSAKO, T. see TAKASE, Y. HARLAND, C.C. and KILBY, P.E. Vasculitis in associ- FUKUZAWA, K. and HORIKOSHI, T. Inhibitory effect on ation with atherosclerosis (Correspondence), 90 human fibroblast interferon (HuIFN-f) on the HAROON, T.S., HUSSAIN, I., MAHMOOD, A., NAGI, growth and invasive potential of cultured human A.H.., AHMAN, I. and ZAHID, M. An open clinical melanoma cells in vitro, 324 pilot study of the efficacy and safety of oral terbina- AUTHOR INDEX 631 fine in dry non-inflammatory tinea capitis. Suppl. 39, IKEZAWA, Z. see SUGITA, Y. 47 INABA, M. see TSUBOI, R. HARPER, J.I. see PHILLIPS, R.]. ISHIDA-YAMAMOTO, A. see MCGRATH, J.A. HARRINGTON, C.I. see MCDONAGH, A.J.G. ISHII, N. see TANI, M. HARRIS, D. see OSTLERE, L.S. ISHIKAWA, H. see AKIMOTO, S. HARRIS, D.W.S., OSTLERE, L., BUCKLEY, C., JOHNSON, IVE, F.A. see COX, N.H. M. and RUSTIN, M.H.A. Eosinophilic pustular folli- JACKSON, J. see COLLINS, P. culitis in an HIV-positive man: response to cetirizine, 392 JANIER, M. see MOISSON, Y.F. JAYSON, M.I.V. see FREEMONT, A.J. HATAMOCHI, A., ONO, M., ARAKAWA, M., TAKEDA, JOHNSON, J.A. Dihydroxyacetone for protection against K. and UEKI, H. Analysis of collagen gene expression long wavelength UVA radiation and blue light by cultured fibroblasts in morphoea, 216 (Correspondence), 94 HAUSMANN, R. see POPE, F.M. JOHNSON, M. see HARRIS, D.W.S HAYASHI, H. see AKIMOTO, S. HEAGERTY, A.H.M. see MCGRATH, J.A. JONES, S.K. The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human HECKMANN, M. see SCHIRREN, C.G. keratinocytes in vitro: their possible role in the HEIN, R., BEHR, J., HUNDGEN, M., HUNZELMANN, N.., induction of cutaneous lupus lesions, 554 MEURER, M., BRAUN-FALCO, O., URBANSKI, A. JONES, S.K. Ultraviolet radiation (UVR) induces and KRIEG, T. Treatment of systemic sclerosis with cell-surface Ro/SSA antigen expression by human y-interferon 496 keratinocytes in vitro: a possible mechanism for the HELM, K.F. see ASLANZADEH, J. UVR induction of cutaneous lupus lesions, 546 HELM, K.F., CERIO, R. and WINKELMANN, R.K. Granu- JONES, T.C. see VILLARS, V.V. lomatous slack skin: a clinicopathological and JORENS, P.G. see AELVOET, G.E. immunohistochemical study of three cases, 142 JUNG, R.T. see PEARS, J.S. HENG, M.C.Y., HENG, S.Y. and ALLEN, S.G. Expression of L-fucose moiety on epidermal keratinocytes in KALIMO, K. see LAINE, J. psoriasis induced by the Koebner phenomenon: a KAPP, A. see CZECH, W. sequential study, 575 KARLBERG, A-T. and LIDEN, C. Colophony (rosin) in HENG, S.Y. see HENG, M.C.Y. newspapers may contribute to hand eczema, 161 HEPBURN, N.C. Dermatological problems in British KASORI, J. see NOGITA, T. troops during the Gulf War (Correspondence), 200 KAWASHIMA, M. see NOGITA, T. HIDANO, A. see NOGITA, T. KECZKES, K. see KO, C.B. HODSON, N. see FREEMONT, A.J. KELLY, S.E., MCVITTIE, E., BLACK, M.M. and FLEMING, HOLDEN, C.A. see COULSON, I.H. S. Isolated basal keratinocytes express pemphigoid HOLLAND, K.T., BOJAR, R.A., CUNLIFFE, W.,]J., gestationis antigen, 42 CUTCLIFFE, A.G., EADY, E.A., FAROOQ, L., KENICER, K. see PEARS, J.S. FARRELL, A.M., GRIBBON, E.M. and TAYLOR, D. KENZELMANN, R. see BAUDRAZ-ROSSELET, F. The effect of zinc and erythromycin on the growth of KIISTALA, R. Adrenaline-induced local sweating and erythromycin-resistant and erythromycin-sensitive vasoconstrictive responses in atopic skin, 246 isolates of Propionibacterium acnes: an in-vitro study, KIISTALA, R. see PARKKINEN, M.U. 505 KIISTALA, U. see OIKARINEN, A. HOLT, P.J.A. see MOTLEY, RJ. KIISTALA, U. see PARKKINEN, M.U. HORI, Y. see NAKAYAMA, J. KIKUCHI, A., SAKURAOKA, K., KURIHARA, S., HORIKAWA, T. see TANI, M. AKIYAMA, M., SHIMIZU, H. and NISHIKAWA, T. HORIKOSHI, T. see FUKUZAWA, K. CD8* cutaneous anaplastic large-cell lymphoma: HOULSTON, R. see BUCKLEY, C. report of two cases with immunophenotyping, T-cell- HOYLAND, J. see FREEMONT, A.J. receptor gene rearrangement and electron micro- HULL, P.R. and VISMER, H.F. Treatment of cutaneous scopic studies, 404 sporotrichosis with terbinafine. Suppl. 39, 51 KILBY, P.E. see HARLAND, C.C. HUMBERT, H. see KOVARIK, J.M. KINT, A. see BARAN, R. HUMPHREYS, W.V. see MORGAN, G.W. KIRKESSELI, S. see KOVARIK, J.M. HUNDGEN, M. see HEIN, R. KIRKHAM, N. see MCGREGOR, J.M. HUNZELMANN, N. see HEIN, R. KO, C.B., WALTON, S., KECZKES, K., GREENSTONE, M. HUNZELMANN, N. see SCHIRREN, C.G. and BURY, H.P.R. AIDS-related Kaposi’s sarcoma in HUTCHINSON, P.E. see BERTH-JONES, J. a heterosexual female, 74 632 AUTHOR INDEX KOLDE, G. and BONSMANN, G. Generalized lichenoid LORETTE, G. see VAILLANT, L. juvenile xanthogranuloma, 66 KOMURA, A. see TANI, M. MCCARTAN, B. see COLLINS, P. KOOPMAN, RJ.J... VAN MERRIENBOER, F.C,J., MCDONAGH, A.J.G., LAING, R.W., HARRINGTON, C.I. VREDEN, S.G.S. and DOLMANS, W.M.V. Molluscum and GRIFFITHS, R.W. Giant alopecic nodule of the contagiosum; a marker for advanced HIV infection scalp: unusual presentation of a cellular blue naevus (Correspondence), 528 in an adult, 375 KOSZO, F., MORVAY, M., DOBOZY, A. and SIMON, N. MCDONAGH, A.J.G., WRIGHT, A.L., CORK, M.J. and Erythrocyte uroporphyrinogen decarboxylase acti- GAWKRODGER, D.J. Nickel sensitivity: the influence vity in 80 unrelated patients with porphyria cutanea of ear piercing and atopy, 16 tarda, 446 MACDONALD, D.M. see BARKER, J.N.W.N. KOVARIK, J.M., KIRKESSELI, S., HUMBERT, H., GRASS, MACDONALD, D.M. see MARKEY, A.C. P. and KUTZ, K. Dose-proportional pharmacokine- MCGIBBON, D.H. see MCGREGOR, J.M. tics of terbinafine and its N-demethylated metabolite MCGINLEY, K.J. see HARKAWAY, K.S. in healthy volunteers. Suppl. 39, 8 MCGRATH, J.A., ISHIDA-YAMAMOTO, A., TIDMAN, KRIEG, T. see HEIN, R. M.J., HEAGERTY, A.H.M., SCHOFIELD, O.M.V. and KRIEG, T. see SCHIRREN, C.G. EADY, R.A.J. Epidermolysis bullosa simplex (Dowl- KRUTMANN, J. see CZECH, W. ing—Meara). A clinicopathological review, 421 KUFFER, R. see BORRADORI, L. MCGREGOR, J.M., NEWELL, M., ROSS, J., KIRKHAM, N., KUMAGAI, M. see TANI, M. MCGIBBON, D.H. and DARLEY, C. Cutaneous malig- KURIHARA, S. see KIKUCHI, A. nant melanoma and human immunodeficiency KUTZ, K. see KOVARIK, J.M. virus (HIV) infection: a report of three cases, 516 KUWAHARA, M. see SEISHIMA, M. MACHADO, P., MICHALAKI, H., ROCHE, P., KWEE, M.L. see POPE, F.M. GAUCHERAND, M., THIVOLET, J. and NICOLAS, J-F. Serological diagnosis of bullous pemphigoid (BP): LACOUR, J.PH. see GALLAIS, V. comparison of the sensitivity of indirect immuno- LAINE, J., KALIMO, K., FORSSELL, H. and HAPPONEN, fluorescence on salt-split skin to immunoblotting, R-P. Resolution of oral lichenoid lesions after replace- 236 ment of amalgam restorations in patients allergic to MACHET, L. see VAILLANT, L. mercury compounds, 10 MCHUGH, M.I. see CARMICHAEL, A.J. LAING, R.W. see MCDONAGH, A.]J.G. MACKIE, R.M. see STABLES, G.I. LAKE, B.D. see PHILLIPS, R.J. MACKIE, R.M. see WILLIAMS, R.E.A. LARGE, D.M. see COX, N.H. MACKIE, R.M. see WILLIAMS, R.E.A. LAWRENCE, C. see RAMSAY, B. MCVITTIE, E. see KELLY, S.E. LEE, W-L. see HARKAWAY, K.S. MAEDA, K., TOMITA, Y., FUKUDA, M. and TAGAMI, H. LEIGH, I. see BOJE RASMUSSEN, H. Effects of staurosporine, PMA and A23187 on LEIGH, I.M. see MARKEY, A.C. human melanocyte cultures with dibutyryl cyclic LEMANN, M. see BORRADORI, L. AMP, 118 LEVER, L.R. see LONG, C.C. MAJEWSKI, S. see SCHIRREN, C.G. LEYDEN, J.J. see HARKAWAY, K.S. MALLET, R.B., CURLEY, G.K. and MORTIMER, P.S. LIDDLE, B.J.,. MARSDEN, J.R. and CRAMB, R.B. Does Acquired lymphangioma: report of four cases and a griseofulvin alter serum lipids? (Correspondence), discussion of the pathogenesis, 380 202 MALLETT, R.B. see COULSON, I.H. LIDEN, C. see KARLBERG, A-T. MARCHESE, C. see PICARDO, M. LINDE, Y.W. see LODEN, M. MARKEY, A.C., BIRGITTE LANE, E., MACDONALD, LINNA, J. see BACK, O. D.M. and LEIGH, I.M. Keratin expression in basal cell LITOUX, P. see DRENO, B. carcinomas, 154 LODEN, M., OLSSON, H., AXELL, T., LINDE, Y.W. MARKS, R. see BARTON, S.P. Friction, capacitance and transepidermal water loss MARKS, R. see ELSAYED-ALI, H. (TEWL) in dry atopic and normal skin, 137 MARKS, R. see LONG, C.C. LONG, C.C., FINLAY, A.Y. and MARKS, R. Fixed drug MARKS, R. British Association of University Teachers of eruption to mefenamic acid: a report of three cases, Dermatology (BAUTOD) (Correspondence), 201 409 MARREN, P. and BURGE, S. Seborrhoeic dermatitis of LONG, C.C., LEVER, L.R. and MARKS, R. Unilateral the scalp—a manifestation of Hailey-Hailey disease bullous pemphigoid in a hemiplegic patient, 614 in a predisposed individual?, 294 AUTHOR INDEX 633 MARREN, P., WOJNAROWSKA, F. and POWELL, S. NAKAJIMA, H. see SUGITA, Y. Allergic contact dermatitis and vulvar dermatoses, NAKAYAMA, J., MOROI, Y., TOSHITANI, A., 52 TANIGUCHI, S., OKAMOTO-INOUE, M. and HORI, Y. MARSDEN, J.R. see LIDDLE, B.J. Responses of B16 melanoma cell lines, F1 and F10, to MARSHALL, J.M. see BURGE, S.M. hyperthermia, lymphokine-activated killer cells and MARTIN, A.M. see CARMICHAEL, A.J. a combination of both in vitro, 131 MARTIN, A.G., WEAVER, C.C., COCKERELL, C.J. and NEILL, S.M. see COLLIER, P.M. BERGER, T.G. Pityriasis rubra pilaris in the setting of NEWELL, M. see MCGREGOR, J.M. HIV infection: clinical behaviour and association NICHOLLS, A.C. see POPE, F.M. with explosive cystic acne, 617 NICOLAS, J-F. see MACHADO, P. MATSUNAGA, J., HARA, M. and TAGAMI, H. Sclere- NIEBOER, C. and VERBURGH, C.A. Psoriasis treatment dema of Buschke associated with malignant insuli- with vitamin D; analogue MC 903 (Correspon- noma (Correspondence), 527 dence), 302 MENON, G.K., GHADIALLY, R., WILLIAMS, M.L. and NILLES, M. see ECKERT, F. ELIAS, P.M. Lamellar bodies as delivery systems of NISHIKAWA, T. see KIKUCHI, A. hydrolytic enzymes: implications for normal and NOGITA, T., NAGAYAMA, M., KAWASHIMA, M., abnormal desquamation, 337 HIDANO, A., KASORI, J. and MORISHIMA, T. Spitz MESSENGER, A.G. see TAYLOR, M. naevus of the toe, 520 MEURER, M. see HEIN, R. NOLTING, S. and BRAUTIGAM, M. Clinical relevance of MICHALAKI, H. see MACHADO, P. the antibacterial activity of terbinafine: A contra- MIELKE, V. see STERRY, W. lateral comparison between 1% terbinafine cream MIHATSCH, M.J. and WOLFF, K. Consensus Conference and 0-1% gentamicin sulphate cream in pyoderma. on cyclosporin A for psoriasis, 621 Suppl. 39, 56 MILLARD, P.R. see DE BERKER, D.A.R. NOMURA, K. see SUGITA, Y. MILLARD, P.R. see VENNING, V.A. NOZAWA, Y. see SEISHIMA, M. MISHIMA, Y. see TANI, M. MODIGLIANI, R. see BORRADORI, L. OGAWA, H. see TSUBOI, R. MOISSON, Y.F., JANIER, M. and CIVATTE, J. Thalido- OIKARINEN, A., AUTIO, P., VUORI, J.. VAANANEN, K., mide for recurrent erythema multiforme (Correspon- RISTELI, L., KIISTALA, U. and RISTELI, J. Systemic dence), 92 glucocorticoid treatment decreases serum concen- MOREL, P. see BORRADORI, L. trations of carboxyterminal propeptide of type 1 MORGAN, G.W., BEER, W.E., WAYTE, D.M. and procollagen and aminoterminal propeptide of type III HUMPHREYS, W.V. Desmoplastic malignant mela- procollagen, 172 noma: a salutary lesson for clinician and dermo- OKAMOTO-INOUE, M. see NAKAYAMA, J. pathologist (Correspondence), 301 OLSSON, H. see LODEN, M. MORI, S. see SEISHIMA, M. O'NEILL, R.C. see HARIA, M. MORIMATSU, M. see TAKASE, Y. ONO, M. see HATAMOCHI, A. MORIOKA, R. see TSUBOI, R. ORMEROD, A. see YEAMAN, G.R. MORISHIMA, T. see NOGITA, T. ORMEROD, A.D. see WAKEEL, R.A. MOROI, Y. see NAKAYAMA, J. ORTONNE, J.P. see GALLAIS, V. MORRIS, C.J. see TRENAM, C.W. OSTLERE, L. see HARRIS, D.W.S. MORTIMER, P. see FIFE, K.M. OSTLERE, L.S., HARRIS, D., GILLESPIE, S.H. and MORTIMER, P.S. see CHOW, E.T.Y. RUSTIN, M.H.A. Acute infectious erythemas in MORTIMER, P.S. see MALLET, R.B. children (Correspondence), 302 MORTIMER, P.S. see BULL, R.H. OTRIDGE, B. see GUDMUNDSEN, K. MORVAY, M. see KOSZO, F. MOTLEY, R.J. and HOLT, P.J.A. A simple device for PALAN, A. see POPE, F.M. optimal tissue preparation for Mohs micrographic PAMPIGLIONE, S., SCHIAVON, S. and FIORAVANTI, surgery, 57 M.L. Extensive furuncular myiasis due to Cordylobia MULLER, S.A. see ASLANZADEH, J. rodhaini larvae (Correspondence), 418 MURPHY, G.M. see GUDMUNDSEN, K. PARKKINEN, M.U., KIISTALA, R. and KIISTALA, U. Sweating response to moderate thermal stress in atopic dermatitis, 346 NAGAO, S. see SEISHIMA, M. PARODI, A. and REBORA, A. Serum IgE antibodies bind NAGATANI, T. see SUGITA, Y. to the epidermal side of the basement zone splits in NAGAYAMA, M. see NOGITA, T. bullous pemphigoid (Correspondence), 526 634 AUTHOR INDEX PARSONS, M.A. see ROGERS, S. RUSTIN, M.H.A. see HARRIS, D.W.S. PATERSON, W.D. see COX, N.H. RUSTIN, M.H.A. see OSTLERE, L.S. PEARS, J.S., JUNG, R.T., BARTLETT, W., BROWNING, RYBOJAD, M. see BORRADORI, L. M.C.K., KENICER, K. and THODY, A.J. A case of skin RYDER, N.S. Terbinafine: Mode of action and properties hyperpigmentation due to «-MSH hypersecretion, of the squalene epoxidase inhibition. Suppl. 39, 2 286 PERKINS, W. see WILLIAMS, R.E.A. SAADA, V. see BORRADORI, L. PERRIN, C. see GALLAIS, V. SAIDA, T. Heterogeneity of the site of origin of malignant PETZELBAUER, P., WOLFF, K. and TAPPEINER, G. melanoma in ungual areas: ‘subungual’ malignant Necrobiosis lipoidica: treatment with systemic melanoma may be a misnomer (Correspondence), corticosteroids, 542 529 PHILLIPS, R.J., HARPER, J.I. and LAKE, B.D. Intraepi- SAKURAOKA, K. see KIKUCHI, A. dermal collagen type VII in dystrophic epidermolysis SALOB, S.P., WEBB, D.K.H. and ATHERTON, D.J. A child bullosa: report of five new cases, 222 with xeroderma pigmentosum and bone marrow PICARDO, M., ZOMPETTA, C., MARCHESE, C., DE failure, 372 LUCA, C., FAGGIONI, A., SCHMIDT, R.J. and SANTUCCI, B. see PICARDO, M. SANTUCCI, B. Paraphenylenediamine, a contact SASASE, A. see TANI, M. allergen, induces oxidative stress and ICAM-1 SAURAT, J-H. see ZURN, A. expression in human keratinocytes, 450 SCHIAVON, S. see PAMPIGLIONE, S. PILLAR, T. see GILHAR, A. SCHIRREN, C.G., MAJEWSKI, S., HUNZELMANN, N., POPE, F.M., NICHOLLS, A.C., PALAN, A., KWEE, M.L., HECKMANN, M. and KRIEG, T. The effect of inter- DE GROOT, W.P. and HAUSMANN, R. Clinical feron-gamma on the invasiveness of HT-180 cells, features of an affected father and daughter with 33] Ehlers—Danlos syndrome type VIIB, 77 SCHMIDT, R.J. see PICARDO, M. POWELL, S. see MARREN, P. SCHOFIELD, O.M.V. see MCGRATH, J.A. POWLES, A.V. see BAKER, B.S. SCHOPF, E. see CZECH, W. SEISHIMA, M., NAGAO, S., KUWAHARA, M., MORI, S. RAFANELLI, S. see BUCCHI, L. and NOZAWA, Y. Increased calmodulin levels in RAKOSI, T. see BAUDRAZ-ROSSELET, F. fibroblasts from progressive systemic sclerosis, 231 RAMSAY, B., RICE, N. and LAWRENCE, C. The effect of SERAFINI, M. see BUCCHI, L. indomethacin on anthralin inflammation, 262 SEWELL, H.F. see WAKEEL, R.A. REBORA, A. see PARODI, A. SHALITA, A.R. see HARKAWAY, K.S. REES, A. see COATES, P. SHEEHAN, M.P. and ATHERTON, D.J. A controlled trial REES, J. The molecular biology of retinoic acid receptors: of traditional Chinese medicinal plants in widespread orphan from good family seeks home (Review), 97 non-exudative atopic eczema, 179 RICE, N. see RAMSAY, B. SHIMIZU, H. see KIKUCHI, A. RISTELI, J. see OIKARINEN, A. SHIMOKAWA, R. see TSUBOI, R. RISTELI, L. see OIKARINEN, A. SHUTTLEWORTH, D. see COATES, P. ROBERT, L. see BRANCHET, M.C. SIEBEL, A. see STERRY, W. ROBERTS, D.T. Prevalence of dermatophyte onychomy- SIMON, N. see KOSZO, F. cosis in the United Kingdom: Results of an omnibus SLACK, J. see BUCKLEY, C. survey. Suppl. 39, 23 SLATER, D.N. see ROGERS, S. ROCHE, P. see MACHADO, P. SLOAN, J. see HANDLEY, J. ROELEN, L.M. see AELVOET, G.E. SMITH, I.E. see FIFE, K.M. ROGERS, S. see COLLINS, P. SMITH, K.C. Hydroxychloroquine is useful in the man- ROGERS, S., SLATER, D.N., ANDERSON, J.A. and agement of atopic dermatitis (Correspondence), 93 PARSONS, M.A. Cutaneous xanthogranulomatous SMITH, N.P. see THOMAS, R.]. inflammation: a potential indicator of internal dis- SMITH, T.F. see ASLANZADEH J. ease, 290 SORENSEN, H. see VAILLANT, L. ROSS, J. see MCGREGOR, J.M. SPITTLE, M.F. see THOMAS, R.J. ROSS, J.S., CERIO, R. and CAMP, R.D.R. Factor XIIa+ STABLES, G.I. and MACKIE, R.M. Generalized eruptive cells in Sweet’s syndrome: the role of interleukin 1 histiocytoma, 196 (Correspondence), 201 STADLER, J.F. see DRENO, B. RUSSELL-JONES, R. see Burrows, N.P. STANGANELLI, I. see BUCCHI, L. RUSTIN, M.H.A. see BUCKLEY, C. STERRY, W., SIEBEL, A. and MIELKE, V. HTLV-1-